Salivary markers and risk factor data: A multivariate modeling approach for head and neck squamous cell carcinoma detection

Cancer Biomarkers

Volumn 10, Issue 5, 2011, Pages 241-249

  Pereira, Lutécia H Mateus ^a   Adebisi, Islamiyat Nancy ^a   Perez, Aymee ^b   Wiebel, Michael ^b   Reis, Isildinha ^a,b   Duncan, Robert ^b   Goodwin, W Jarrard ^a,b   Hu, Jennifer J ^a,b   Lokeshwar, Vinata B ^b   Franzmann, Elizabeth J ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CD44; head and neck cancer; hyaluronic acid; IL 8; protein

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 8; SOLUBLE CD44 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUESTIONNAIRE; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; RISK FACTORS; SALIVA; SALIVARY GLANDS; TUMOR MARKERS, BIOLOGICAL;

NICOTIANA TABACUM;

EID: 84862869577     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0252     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer Society; 2011.
2. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002, CA Cancer J Clin 55 (2005), 74-108. (Pubitemid 40372904)
3. M.L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begumet al., Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers, J Natl Cancer Inst 100 (2008), 407-420. (Pubitemid 351480511)
4. H.S. Lin, H.S. Talwar, A.L. Tarca, A. Ionan, M. Chatterjee, B. Yeet al., Autoantibody approach for serum-based detection of head and neck cancer, Cancer Epidemiol Biomarkers Prev 16 (2007), 2396-2405. (Pubitemid 351196373)
5. M.W. Lingen, J.R. Kalmar, T. Karrison, P.M. Speight, Critical evaluation of diagnostic aids for the detection of oral cancer, Oral Oncol 44 (2008), 10-22. (Pubitemid 350258631)
6. Y. Li, M.A. St John, X. Zhou, Y. Kim, U. Sinha, R.C. Jordanet al., Salivary transcriptome diagnostics for oral cancer detection, Clin Cancer Res 10 (2004), 8442-8450. (Pubitemid 40053408)
7. N.J. Park, H. Zhou, D. Elashoff, B.S. Henson, D.A. Kastratovic, E.Abemayoret al., Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection, Clin Cancer Res 15 (2009), 5473-5477.
8. S. Hu, M. Arellano, P. Boontheung, J. Wang, H. Zhou, J. Jianget al., Salivary proteomics for oral cancer biomarker discovery, Clin Cancer Res 14 (2008), 6246-6252.
9. E.P. Reategui, A.A. de Mayolo, P.M. Das, F.C. Astor, R. Singal, K.L. Hamiltonet al., Characterization of CD44v3-containing isoforms in head and neck cancer, Cancer Biol Ther 5 (2006), 1163-1168. (Pubitemid 44772233)
10. E. Ioachim, D. Assimakopoulos, A.C. Goussia, D. Peschos, A. Skevas, N.J. Agnantis, Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA, Histol Histopathol 14 (1999), 1113-1118. (Pubitemid 29447452)
11. L.Y. Bourguignon, E. Gilad, A. Brightman, F. Diedrich, P. Singleton, Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells, J Biol Chem 281 (2006), 14026-14040. (Pubitemid 43848329)
12. E.J. Franzmann, G.L. Schroeder, W.J. Goodwin, D.T. Weed, P. Fisher, V.B. Lokeshwar, Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors, Int J Cancer 106 (2003), 438-445. (Pubitemid 36870409)
13. M.A. St John, Y. Li, X. Zhou, P. Denny, C.M. Ho, C. Montemagnoet al., Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma, Arch Otolaryngol Head Neck Surg 130 (2004), 929-935. (Pubitemid 39045599)
14. R.R.-S. Lucille Beaudet, Marie-HélèneVenne, Mireille Caron, Julie Bédard, Véronique Brechler, Stéphane Parent, et al., AlphaLISA immunoassays: the no-wash alternative to ELISAs for research and drug discovery, Nature Methods 5 (2008).
15. L. Savage, Is an improved PSA screening test in sight? J Natl Cancer Inst 99 (2007), 1503-1504.
16. E.J. Franzmann, E.P. Reategui, F. Pedroso, F.G. Pernas, B.M. Karakullukcu, K.L. Carrawayet al., Soluble CD44 is a potential marker for the early detection of head and neck cancer, Cancer Epidemiol Biomarkers Prev 16 (2007), 1348-1355. (Pubitemid 47076863)
17. W.J. Goodwin, G.R. Thomas, D.F. Parker, D. Joseph, S. Levis, E. Franzmannet al., Unequal burden of head and neck cancer in the United States, Head Neck 30 (2008), 358-371. (Pubitemid 351480753)
18. P. Brocklehurst, O. Kujan, A.M. Glenny, R. Oliver, P. Sloan, G. Ogdenet al., Screening programmes for the early detection and prevention of oral cancer, Cochrane Database Syst Rev 11 (2010), CD004150.
19. A. Larsson, T. Axell, G. Andersson, Reversibility of snuff dippers' lesion in Swedish moist snuff users: a clinical and histologic follow-up study, J Oral Pathol Med 20 (1991), 258-264.
20. R.E. Franzmann EJ, Mateus Pereira LH, Pedroso F, Joseph D, Allen GO, et al., Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma, Head And Neck Jul 11. doi: 10.1002/hed.21810. [Epub ahead of print] (2011).
21. D.A. Scott, J.A. Stapleton, R.M. Palmer, R.F. Wilson, G. Sutherland, P.Y. Cowardet al., Plasma concentrations of reputed tumor-associated soluble CD44 isoforms (v5 and v6) in smokers are dose related and decline on smoking cessation, Cancer Epidemiol Biomarkers Prev 9 (2000), 1211-1214.
22. R.M. Palmer, J.A. Stapleton, G. Sutherland, P.Y. Coward, R.F. Wilson, D.A. Scott, Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6), Eur J Clin Invest 32 (2002), 852-857. (Pubitemid 35356938)
23. N. Guha, P. Boffetta, V.Wunsch Filho, J. Eluf Neto, O. Shangina, D. Zaridzeet al., Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies, Am J Epidemiol 166 (2007), 1159-1173. (Pubitemid 350022751)
24. M. Hashibe, P. Brennan, S. Benhamou, X. Castellsague, C. Chen, M.P. Curadoet al., Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium, J Natl Cancer Inst 99 (2007), 777-789. (Pubitemid 47073524)
25. C.F. Poh, S.P. Ng, P.M. Williams, L. Zhang, D.M. Laronde, P. Laneet al., Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple handheld device, Head Neck 29 (2007), 71-76. (Pubitemid 46032570)
26. M.E. Prince, R. Sivanandan, A. Kaczorowski, G.T.Wolf, M.J. Kaplan, P. Dalerbaet al., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proc Natl Acad Sci U S A 104 (2007), 973-978. (Pubitemid 46154721)
27. F. Linkov, A. Lisovich, Z. Yurkovetsky, A. Marrangoni, L. Velikokhatnaya, B. Nolenet al., Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling, Cancer Epidemiol Biomarkers Prev 16 (2007), 102-107. (Pubitemid 46174271)
28. A.S. Gokhale, R.I.Haddad, L.A. Cavacini, L.Wirth, L.Weeks, M. Hallaret al., Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck, Oral Oncol 41 (2005), 70-76. (Pubitemid 39647122)
29. C.H. Shiboski, B.L. Schmidt, R.C. Jordan, Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years, Cancer 103 (2005), 1843-1849. (Pubitemid 40563256)